Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Gross Margin: 2012-2024

Historic Gross Margin for OptimizeRx (OPRX) over the last 13 years, with FY2024 value amounting to 64.45%.

  • OptimizeRx's Gross Margin rose 40900.0% to 67.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.31%, marking a year-over-year increase of 27100.0%. This contributed to the annual value of 64.45% for FY2024, which is 44700.0% up from last year.
  • As of FY2024, OptimizeRx's Gross Margin stood at 64.45%, which was up 44700.0% from 59.98% recorded in FY2023.
  • In the past 5 years, OptimizeRx's Gross Margin ranged from a high of 64.45% in FY2024 and a low of 55.65% during FY2020
  • Moreover, its 5-year median value for Gross Margin was 59.98% (2023), whereas its average is 60.13%.
  • In the last 5 years, OptimizeRx's Gross Margin crashed by -71100bps in 2020 and then skyrocketed by 44700bps in 2024.
  • Annual analysis of 5 years shows OptimizeRx's Gross Margin stood at 55.65% in 2020, then increased by 4bps to 58.14% in 2021, then rose by 7bps to 62.4% in 2022, then fell by -4bps to 59.98% in 2023, then grew by 7bps to 64.45% in 2024.
  • Its Gross Margin stands at 64.45% for FY2024, versus 59.98% for FY2023 and 62.4% for FY2022.